Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100256
Status:
RECRUITING
Last Update Posted:
2022-11-07
First Post:
2004-12-27
Brief Title:
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Sponsor:
Andarix Pharmaceuticals
Organization:
Andarix Pharmaceuticals
Organization Data
Organization:
Andarix Pharmaceuticals
Class:
INDUSTRY
Study ID:
91168
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Andarix Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None